BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02186301-completion@plaintrial.com
DTSTAMP:20261029T100434Z
DTSTART;VALUE=DATE:20170628
SUMMARY:TIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlo
 tinib in Patients With EGFR-mutant/Metastatic NSCLC Who Have Not Had Any P
 revious EGFR Directed Therapy — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT02186301
URL:https://plaintrial.com/trial/NCT02186301
END:VEVENT
END:VCALENDAR